These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6973859)

  • 1. Functional cytotoxic T lymphocyte hybridomas.
    Kaufmann Y; Berke G; Eshhar Z
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1170-4. PubMed ID: 6973859
    [No Abstract]   [Full Text] [Related]  

  • 2. LYT-2 negative and T cell growth factor independent cytotoxic T lymphocyte hybridomas.
    Kaufmann Y
    Adv Exp Med Biol; 1982; 146():435-46. PubMed ID: 6980569
    [No Abstract]   [Full Text] [Related]  

  • 3. The early appearance of specific cytotoxic T cells in murine gut mucosa.
    Davies MD; Parrott DM
    Clin Exp Immunol; 1980 Nov; 42(2):273-9. PubMed ID: 6970637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of parental T lymphocytes for the in vitro induction of F1 hybrid anti-parent cytotoxicity.
    Nakamura I; Cudkowicz G
    Eur J Immunol; 1979 May; 9(5):371-9. PubMed ID: 158532
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic and genetic parameters in the stimulation and in the lytic phases of anti-hapten + self cytotoxic T cells and their derived clones: role of the T helper cell.
    Schmitt-Verhulst AM; Albert F; Guimezanes A; Buferne M
    J Supramol Struct Cell Biochem; 1981; 16(4):359-70. PubMed ID: 6975828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression and restoration of cytotoxic T-cell activity during chemotherapy of a mouse T-cell lymphoma and a macrophage tumor.
    Tarnowski GS; Faanes RB; Ralph P; Williams N
    Cancer Res; 1978 Dec; 38(12):4540-5. PubMed ID: 309790
    [No Abstract]   [Full Text] [Related]  

  • 7. Native anti-tumor responses elicited by immunization with a low dose of unmodified live tumor cells.
    Wu S; Wang SQ; Zhang J; Tan XY; Liu JN
    Int J Oncol; 2006 Mar; 28(3):731-6. PubMed ID: 16465379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity.
    Conzelmann A; Corthésy P; Cianfriglia M; Silva A; Nabholz M
    Nature; 1982 Jul; 298(5870):170-2. PubMed ID: 6979720
    [No Abstract]   [Full Text] [Related]  

  • 10. [Human interleukin 2].
    Chouaib S; Fradelizi D
    Ann Immunol (Paris); 1983; 134D(2):157-65. PubMed ID: 6419669
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immune responses to fusion of normal cells and those of tumor-bearing mice].
    Tachibana T
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(12):797-802. PubMed ID: 314526
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens.
    Trinchieri G; Aden DP; Knowles BB
    Nature; 1976 May; 261(5558):312-4. PubMed ID: 179019
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 14. T cell tumors, clones, and hybrids.
    Ruddle NH
    Prog Allergy; 1981; 29():222-68. PubMed ID: 7036181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.